Conferences & Events
BRACHA provides a warm and caring community to all those with high risk or those diagnosed with hereditary cancers and their families, as well as advocating for the rights of the BRACHA community.
BRACHA was founded by Lisa Cohen in loving memory of both her mother and sister who tragically passed away from Hereditary Breast and Ovarian Cancer. BRACHA is based in Israel where it works with Jews and Arabs alike and is also very active within HBOC organisations and medical professions internationally. BRACHA is run 100% by volunteers and all of all donations are used to run the BRACHA programs.
In the general population 1 in 400 people have a mutation in the BRCA gene but 1 in 40 Jewish people have it. Women with a BRCA mutation have a much higher lifetime risk for breast cancer, up to 87%, some 6-7 fold, much of the risk occurs at a younger age. Women with a BRCA mutation have a much higher lifetime risk, up to 50%, up to 25 fold, to develop ovarian cancer.
Welcome to BRACHA – Living with a high risk of hereditary cancer
The BRACHA website is for all those who are affected by Hereditary Breast and Ovarian Cancer (HBOC) and other hereditary cancers: pancreatic cancer, prostate cancer and melanoma. We want to help you assess if you are at high risk and give you the tools that will empower you to reduce your risk. BRACHA wishes to give you the strength and support necessary to face this challenge and lead a fulfilling life.
The BRACHA community is diverse: Healthy BRCA mutation carriers (women and men), Previvors – women who have undergone risk reducing surgery, women with breast cancer, breast cancer survivors, women with ovarian cancer and women with metastatic breast cancer.
BRACHA – Living with a high risk of hereditary cancer is an Israeli non-profit voluntary organisation, registered number 580508075. Since its foundation in 2009, BRACHA has focused on raising awareness about HBOC - Hereditary Breast and Ovarian Cancers. The aim of BRACHA is to provide current knowledge and education about genetic testing, ways to reduce the risk of HBOC and information on research and medical innovations.